Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

HLA-DR Antibody (TAL 8.1), DyLight 755, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NB1002708IR

Catalog No. NB1002708IR


Only null left
Add to Cart

Description

Description

HLA-DR Monoclonal specifically detects HLA-DR in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry-Frozen.
Specifications

Specifications

HLA-DR
Monoclonal
DyLight 755
50mM Sodium Borate with 0.05% Sodium Azide
HLA-DRA
Cells from the B line WVB coated with mouse antiserum followed by WVB class II antigen.
0.1 mL
Adaptive Immunity, B Cell Development and Differentiation Markers, Cell Biology, Cellular Markers, Diabetes Research, Immunology, Major Histocompatibility Complexes
3122
Human
Purified
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry (Frozen)
TAL 8.1
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry
FLJ51114, histocompatibility antigen HLA-DR alpha, HLA class II histocompatibility antigen, DR alpha chain, HLA-DRA1, major histocompatibility complex, class II, DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA, MLRW
Mouse
Protein A purified
RUO
Primary
Specific for Human Leukocyte Antigens DR3, 6, 11, DRJ25. May be used for HLA typing.
Store at 4C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.